Related by context. Frequent words. (Click for all words.) 64 CYT# 63 Phase Ib 62 preclinical studies 61 perifosine 61 picoplatin 60 XL# [003] 60 preclinical 59 Phase 1b 59 RDEA# 58 AEOL # 58 pharmacodynamic 58 RG# [001] 58 elesclomol 58 tivozanib 58 carfilzomib 57 monoclonal antibody 57 MGCD# [002] 57 nimotuzumab 57 Phase 2a 57 antitumor activity 57 tolerability profile 57 CUDC 57 antiviral activity 56 tolerability 56 bortezomib 56 PMX # 56 immunogenicity 56 gemcitabine 56 sunitinib 56 ANA# 55 T DM1 55 AEZS 55 Phase IIa clinical 55 dose escalation study 55 docetaxel 54 dose escalation 54 ipilimumab 54 anticancer 54 Tovaxin 54 INCB# [002] 54 Phase 2a clinical 54 FOLOTYN 54 gefitinib 54 Prochymal 54 ENMD 54 taxane 53 pharmacokinetic profile 53 efficacy 53 satraplatin 53 Phase 2b study 53 carboplatin 53 Phase III clinical 53 therapeutic antibody 53 REOLYSIN R 53 Phase 2b clinical 53 Phase IIb clinical 52 erlotinib 52 sorafenib 52 AZD# 52 ARRY 52 preclinical models 52 laquinimod 52 mipomersen 52 Phase IIa 52 taxanes 52 NKTR 52 pharmacokinetics 52 APD# 51 PLX# 51 Phase III 51 immunotherapeutic 51 chemotherapeutic agents 51 Phase 2b 51 antibody 51 VELCADE 51 antisense 51 cancer immunotherapy 51 humanized monoclonal antibody 51 hematological malignancies 51 monoclonal antibodies 51 rituximab 51 pharmacokinetic 51 dosing regimens 51 investigational compound 51 REOLYSIN 51 bevacizumab 51 AVEO 50 pivotal Phase III 50 safety tolerability 50 cisplatin 50 sitagliptin 50 Locteron 50 investigational drug 50 ALKS 50 arimoclomol 50 immunotherapy 50 Hematide 50 Phase II 50 BiovaxID 50 lapatinib 50 Phase III trials